Skip to main content

Table 2 Summary demographics of the independent neurologically normal CSF/serum matched cohort

From: CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology

 

n

Gender (M:F)

Age (mean years ± SD)

Albumin ratio

CSF/serum cohort

23

12:11

58.13 ± 20.25

9.04 ± 1.19

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193